The long and short of it: using the new factor products.

Abstract excerpt

Hemophilia A (HA) and B (HB) are classified as mild (>5%-40%) moderate (1%-5%) and severe (<1%) disease based on plasma factor activity. Severity of bleeding is commensurate with baseline factor levels in general; however, heterogeneity of bleeding in patients is well described. Recurrent bleeding with painful and disabling musculoskeletal complications is the largest source of morbidity for persons with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Factor IX
• Share to Factor VIII
• Share to Half-Life